This company has been marked as potentially delisted and may not be actively trading. Sinovac Biotech (SVA) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisCompetitorsDividendFDA EventsHeadlinesOptions ChainOwnershipTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sinovac Biotech (NASDAQ:SVA)Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$39.30MNumber ofInstitutional Sellers(last 12 months)0 Get SVA Insider Trade Alerts Want to know when executives and insiders are buying or selling Sinovac Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SVA Institutional Buying and Selling by Quarter Sinovac Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bank of America Corp DE5,886$38K0.0%N/A0.006% 8/14/2025 Vivo Capital LLC5,903,000$38.19M3.9%N/A5.924% 8/14/2025 California Public Employees Retirement System68,732$445K0.0%N/A0.069% 8/13/2025 Skandinaviska Enskilda Banken AB publ 40,000$259K0.0%N/A0.040% 8/11/2025 Spark Investment Management LLC29,100$188K0.5%N/A0.029% 8/8/2025 Geode Capital Management LLC27,717$179K0.0%N/A0.028% 4/22/2024 Vivo Capital LLC11,800,000$76.35M6.0%N/A0.000% 10/26/2023 Yorktown Management & Research Co Inc149,786$969K1.1%+100.0%0.151% 7/28/2023 Yorktown Management & Research Co Inc74,893$291K0.3%N/A0.075% 8/12/2021 Eqis Capital Management Inc.17,879$116K0.0%-48.8%0.018% (Data available from 1/1/2016 forward) SVA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SVA shares? During the previous two years, the following institutional investors and hedge funds held shares of Sinovac Biotech shares: Vivo Capital LLC ($38.19M), Yorktown Management & Research Co Inc ($969K), California Public Employees Retirement System ($445K), Skandinaviska Enskilda Banken AB publ ($259K), Spark Investment Management LLC ($188K), and Geode Capital Management LLC ($179K), and Bank of America Corp DE ($38K).Learn more on Sinovac Biotech's institutional investors. Which institutional investors have been buying Sinovac Biotech's stock? The following institutional investors have purchased Sinovac Biotech's stock in the last 24 months: Vivo Capital LLC ($17.70M), Yorktown Management & Research Co Inc ($74.89K), California Public Employees Retirement System ($68.73K), Skandinaviska Enskilda Banken AB publ ($40K), Spark Investment Management LLC ($29.10K), Geode Capital Management LLC ($27.72K), and Bank of America Corp DE ($5.89K). How much institutional buying is happening at Sinovac Biotech? Institutional investors have bought a total of 6,074,435 shares in the last 24 months. This purchase volume represents approximately $39.30M in transactions. Related Companies KNSA Major Shareholders LQDA Major Shareholders TARS Major Shareholders FOLD Major Shareholders IBRX Major Shareholders DNLI Major Shareholders AGIO Major Shareholders GLPG Major Shareholders IDYA Major Shareholders HRMY Major Shareholders This page (NASDAQ:SVA) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinovac Biotech, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinovac Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access